Rheumatic fever in a developed country – is it still relevant? A retrospective, 25 years follow-up
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Rheumatic fever in a developed country – is it still relevant? A retrospective, 25 years follow-up ; volume:20 ; number:1 ; day:15 ; month:3 ; year:2022 ; pages:1-8 ; date:12.2022
Pediatric rheumatology ; 20, Heft 1 (15.3.2022), 1-8, 12.2022
- Urheber
-
Tal, Rotem
Hamad Saied, Mohamad
Zidani, Razi
Levinsky, Yoel
Straussberg, Rachel
Amir, Jacob
Amarilyo, Gil
Harel, Liora
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12969-022-00678-7
- URN
-
urn:nbn:de:101:1-2022061810310778119919
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tal, Rotem
- Hamad Saied, Mohamad
- Zidani, Razi
- Levinsky, Yoel
- Straussberg, Rachel
- Amir, Jacob
- Amarilyo, Gil
- Harel, Liora
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pathology and therapy of rheumatic fever
Immunopathology of rheumatic fever and rheumatoid arthritis
Cardiac magnetic resonance in acute rheumatic fever
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia
Secondary prophylaxis in rheumatic fever: is it time to change?
Differentiation of post streptococcal reactive arthritis from acute rheumatic fever
Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease
MBL2 gene polymorphism rs1800450 and rheumatic fever with and without rheumatic heart disease: an Egyptian pilot study
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis
Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach
Pathology and therapy of rheumatic fever
Immunopathology of rheumatic fever and rheumatoid arthritis
Cardiac magnetic resonance in acute rheumatic fever
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia
Secondary prophylaxis in rheumatic fever: is it time to change?
Differentiation of post streptococcal reactive arthritis from acute rheumatic fever
Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease
MBL2 gene polymorphism rs1800450 and rheumatic fever with and without rheumatic heart disease: an Egyptian pilot study
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis
Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach
Pathology and therapy of rheumatic fever
Immunopathology of rheumatic fever and rheumatoid arthritis
Cardiac magnetic resonance in acute rheumatic fever
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia
Secondary prophylaxis in rheumatic fever: is it time to change?
Differentiation of post streptococcal reactive arthritis from acute rheumatic fever
Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease
MBL2 gene polymorphism rs1800450 and rheumatic fever with and without rheumatic heart disease: an Egyptian pilot study
Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis